Rationale, design, and baseline data of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study: A multinational, randomized noninferiority trial of basal insulin initiation in type 2 diabetes

S.G. Swinnen, F.J. Snoek, M.P. Dain, J.H. de Vries, J. Hoekstra-Slikkerveer, F. Holleman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)739-743
JournalDiabetes Technology and Therapeutics
Volume11
Issue number11
DOIs
Publication statusPublished - 2009

Cite this

@article{b9fde94f122a453faa5272702e67c9ea,
title = "Rationale, design, and baseline data of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study: A multinational, randomized noninferiority trial of basal insulin initiation in type 2 diabetes",
author = "S.G. Swinnen and F.J. Snoek and M.P. Dain and {de Vries}, J.H. and J. Hoekstra-Slikkerveer and F. Holleman",
year = "2009",
doi = "10.1089/dia.2009.0044",
language = "Undefined/Unknown",
volume = "11",
pages = "739--743",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - Rationale, design, and baseline data of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study: A multinational, randomized noninferiority trial of basal insulin initiation in type 2 diabetes

AU - Swinnen, S.G.

AU - Snoek, F.J.

AU - Dain, M.P.

AU - de Vries, J.H.

AU - Hoekstra-Slikkerveer, J.

AU - Holleman, F.

PY - 2009

Y1 - 2009

U2 - 10.1089/dia.2009.0044

DO - 10.1089/dia.2009.0044

M3 - Article

VL - 11

SP - 739

EP - 743

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 11

ER -